| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/24/2013 | WO2013158046A1 Rnai-based therapies for cardiomyopathies, muscular dystrophies and laminopathies |
| 10/24/2013 | WO2013157984A1 preparation and method for the prophylaxis and treatment of osteoporosis and bone fractures |
| 10/24/2013 | WO2013157982A1 Preparation and method for the prophylaxis and treatment of atypical osteoporosis |
| 10/24/2013 | WO2013157967A1 The use of dextran derivatives in preventing or treating anemia. |
| 10/24/2013 | WO2013157961A1 Immunostimulatory compositions and methods of manufacture |
| 10/24/2013 | WO2013157955A1 Geranyl geranyl acetone analogs and uses thereof |
| 10/24/2013 | WO2013157926A1 Geranyl geranyl acetone analogs and uses thereof |
| 10/24/2013 | WO2013157889A1 Use of a novel aminopyridine derivative to prevent or treat cancer |
| 10/24/2013 | WO2013157841A1 Sustained release tablet containing levodropropizine and method for preparing same |
| 10/24/2013 | WO2013157840A1 Composite composition having improved stability and containing amlodipine and rozaltan |
| 10/24/2013 | WO2013157833A1 Composition including beta-blocker as an active principle for treating or improving obesity, metabolic diseases, and osteopenia |
| 10/24/2013 | WO2013157792A1 Bicyclic heteroaryl derivative and pharmaceutical composition comprising same |
| 10/24/2013 | WO2013157754A1 Method for preparing low dosage entecavir formulation for oral administration |
| 10/24/2013 | WO2013157749A1 Composition for preventing hair loss or promoting hair growth containing octaphlorethol a (opa) as active ingredient |
| 10/24/2013 | WO2013157728A1 Pharmaceutical composition for preventing or treating dementia, and preparation method thereof |
| 10/24/2013 | WO2013157665A1 Fatty acid derivative-polymer conjugate |
| 10/24/2013 | WO2013157664A1 Tricyclo compound-polymer conjugate |
| 10/24/2013 | WO2013157622A1 Hiv replication inhibitor |
| 10/24/2013 | WO2013157584A1 Encapsulated formulation |
| 10/24/2013 | WO2013157583A1 Novel carbapenem compound |
| 10/24/2013 | WO2013157562A1 Nitrogenated bicyclic aromatic heterocyclic compound |
| 10/24/2013 | WO2013157555A1 Novel aplysiatoxin derivative and anticancer agent containing same |
| 10/24/2013 | WO2013157540A1 Nitrogen-containing heterocyclic compound or salt thereof |
| 10/24/2013 | WO2013157528A1 Bicyclic compound |
| 10/24/2013 | WO2013157511A1 Arylaminopyrazole derivative |
| 10/24/2013 | WO2013157022A1 Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof |
| 10/24/2013 | WO2013157021A1 Bicyclic compounds, compositions and medicinal applications thereof |
| 10/24/2013 | WO2013157010A1 Methods and compositions for rnai-based cancer treatment |
| 10/24/2013 | WO2013157005A1 Methods and compositions for treating viral infections |
| 10/24/2013 | WO2013156971A1 Composition comprising alpha- lipoic acid and honokiol for treating neuropathies |
| 10/24/2013 | WO2013156957A1 Compounds for the prevention or treatment of infections with viruses of the flaviviridae family |
| 10/24/2013 | WO2013156869A1 Treatment of diseases by epigenetic regulation |
| 10/24/2013 | WO2013156861A2 Methods and compounds for treating proliferative disorders and viral infections |
| 10/24/2013 | WO2013156858A1 Materials and methods for prevention and treatment of viral infections |
| 10/24/2013 | WO2013156853A1 Method of treating acne |
| 10/24/2013 | WO2013156850A1 Systems and methods for treating an opioid-induced adverse pharmacodynamic response |
| 10/24/2013 | WO2013156835A1 An improved process for the preparation of erlotinib hydrochloride form a |
| 10/24/2013 | WO2013156782A1 3- (1' -adamantyl) - 1 - aminomethyl - 3, 4 - dihydro - 5, 6 - dihydroxy - 1h - 2 - benzopyran for use in the treatment of a disease associated with beta-amyloid induced toxicity |
| 10/24/2013 | WO2013156780A1 Therapeutic compounds |
| 10/24/2013 | WO2013156772A1 Crystalline forms of (s) -4-amino-n- (1- (4 - chlorophenyl) - 3 - hydroxypropyl) -1- (7h - pyrrolo [2, 3-d] pyrimidi n-4-yl) piperidine-4-carboxamide |
| 10/24/2013 | WO2013156659A1 Antitumour activity of taiwaniaquinoids and related compounds |
| 10/24/2013 | WO2013156630A1 S-enantiomer of a tri-substituted glycerol compound |
| 10/24/2013 | WO2013156614A1 Methods for treating parkinson's disease |
| 10/24/2013 | WO2013156608A1 Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments |
| 10/24/2013 | WO2013156505A1 Agents for treating disorders involving modulation of ryanodine receptors |
| 10/24/2013 | WO2013156473A1 Combination therapy of anti-mif antibodies and chemotherapeutics |
| 10/24/2013 | WO2013156472A1 Combination therapy of anti-mif antibodies and glucocorticoids |
| 10/24/2013 | WO2013156423A1 New phenyl-tetrahydroisoquinoline derivatives |
| 10/24/2013 | WO2013156413A1 Methods of treating lactose intolerance |
| 10/24/2013 | WO2013156329A1 Estrogenic components for use in the treatment of neurological disorders. |
| 10/24/2013 | WO2013156232A1 Use of benzofuranylsulfonates in neuropathic pain |
| 10/24/2013 | WO2013156231A1 Use of imidazotriazinones in neuropathic pain |
| 10/24/2013 | WO2013156225A1 Optimizing ungual treatment by quantitative autoradiography |
| 10/24/2013 | WO2013156155A1 Substituted 4-aminobenzamides as kcnq2/3 modulators |
| 10/24/2013 | WO2013156154A1 Substituted 6-amino-nicotinamides bearing an oh-containing group as kcnq2/3 modulators |
| 10/24/2013 | WO2013156088A1 Pellets comprising high active ingredient content |
| 10/24/2013 | WO2013156035A1 Orally available pharmaceutical formulation suitable for improved management of movement disorders |
| 10/24/2013 | WO2013155980A1 Auto-immune disease-related microrna and use thereof |
| 10/24/2013 | WO2013155739A1 Application of pigeon pea ketonic acid a in preparation of medicine for diabetes-accompanying disease and hyperlipidemia |
| 10/24/2013 | WO2013155695A1 Isoindolone derivatives |
| 10/24/2013 | WO2013155632A1 Intra-oral light-therapy apparatuses and methods for their use |
| 10/24/2013 | WO2013155600A1 Fused aromatic phosphonate derivatives as precursors to ptp-1b inhibitors |
| 10/24/2013 | WO2013155595A1 Process for the preparation of a monosodium salt of h-d-glu-(l-trp-oh)-oh and a crystalline form thereof |
| 10/24/2013 | WO2013155592A1 Crystal forms of golotimod and process for its manufacturing |
| 10/24/2013 | WO2013155586A1 Process for preparing inclusion compounds enclosing cyclodextrins and drugs, using a continuous-flow system |
| 10/24/2013 | WO2013155585A1 Sustained release device for thalidomide and use in eye diseases causing neovascularisation |
| 10/24/2013 | WO2013155584A1 Topical pharmaceutical composition, method for producing the topical pharmaceutical composition, use of the topical pharmaceutical composition and method for the topical treatment of psoriasis, atopic dermatitis or chronic eczema |
| 10/24/2013 | WO2013134407A3 Procaspase 3 activation by combination therapy |
| 10/24/2013 | WO2013134081A3 Halogenated compounds for photodynamic therapy |
| 10/24/2013 | WO2013130785A3 Extended release pharmaceutical formulations of water-soluble active pharmaceutical ingredients and methods for making the same |
| 10/24/2013 | WO2013130150A9 Metalloporphyrin neurological treatments |
| 10/24/2013 | WO2013129889A3 High-content fast dissolving film with masking of bitter taste comprising sildenafil as active ingredient |
| 10/24/2013 | WO2013119916A3 Compounds for treating spinal muscular atrophy |
| 10/24/2013 | WO2013115736A3 Bilayer tablet formulations of flurbiprofen and glucosamin |
| 10/24/2013 | WO2013109323A3 Topical dtpa prodrug formulations and methods of using the same |
| 10/24/2013 | WO2013093508A3 Wnt pathway inhibitors |
| 10/24/2013 | WO2013083910A3 Topical emulsions based on mixtures of local eutectic anaesthetics and fatty acids as analgesics, antalgics, or as sexual retardants |
| 10/24/2013 | WO2013072770A3 Pharmaceutical formulations comprising atorvastatin and glimepiride |
| 10/24/2013 | WO2013061309A3 New a-prp medical device & tissue engineering composition, manufacturing machines and process |
| 10/24/2013 | WO2013022846A3 Flavonoid compounds |
| 10/24/2013 | WO2012137106A8 The treatment of viral infections |
| 10/24/2013 | WO2012136080A8 Benzomorpholine derivatives, preparation method and use thereof |
| 10/24/2013 | WO2012134184A8 Novel cephalosporin derivatives and pharmaceutical compositions thereof |
| 10/24/2013 | WO2012125746A9 Tricyclic gyrase inhibitors |
| 10/24/2013 | WO2012092373A3 In vivo polynucleotide delivery conjugates having enzyme sensitive linkages |
| 10/24/2013 | WO2012051105A3 Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the same |
| 10/24/2013 | WO2012047763A3 Stimulation of neuroregeneration by flavonoid glycosides |
| 10/24/2013 | WO2011085326A9 D- amino acids for use in treating biofilms |
| 10/24/2013 | US20130281975 Method for vector delivery |
| 10/24/2013 | US20130281712 Dosage Regimen of an S1P Receptor Agonist |
| 10/24/2013 | US20130281705 Compounds for the treatment of metabolic disorders |
| 10/24/2013 | US20130281704 Salts of benzimidazole compound and use thereof |
| 10/24/2013 | US20130281703 Small Molecules Modulator of Epigenetic Regulation and Their Therapeutic Applications |
| 10/24/2013 | US20130281685 iRNA AGENTS WITH BIOCLEAVABLE TETHERS |
| 10/24/2013 | US20130281634 Method of Preparing Carboxylic Acid Functionalized Polymers |
| 10/24/2013 | US20130281545 Protection Against Sunburn And Skin Problems With Topical And Orally-Ingested Dosages Of Zeaxanthin |
| 10/24/2013 | US20130281544 Hepatoprotectant activity of garcinol |
| 10/24/2013 | US20130281543 Method of treating airway remolding symptom |
| 10/24/2013 | US20130281542 Selegiline transdermal system |
| 10/24/2013 | US20130281541 Use in brain degenerative diseases |